Literature DB >> 1694126

Identification and characterization of C-terminal fragments of the beta-amyloid precursor produced in cell culture.

D Wolf1, D Quon, Y Wang, B Cordell.   

Abstract

The mechanism of amyloid formation in Alzheimer's disease is unknown but appears to involve proteolytic processing of the amyloidogenic peptide from a larger precursor. When the C-terminus containing the amyloid-forming and cytoplasmic domains of the precursor was recombinantly expressed in cultured mammalian cells, a 16 kd protein accumulated which had a tendency to aggregate and form deposits. These deposits had physical characteristics resembling those of preamyloid. Recombinant expression of the full-length precursor was found to produce a similar, cell-associated 16 kd C-terminal fragment as well as a 12 kd fragment, neither of which formed detectable aggregates suggesting efficient catabolism of these fragments. Identification of these two naturally occurring metabolic products of the beta-amyloid precursor provides a system permitting the characterization of the proteolytic processing events of the amyloid precursor protein.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1694126      PMCID: PMC551925          DOI: 10.1002/j.1460-2075.1990.tb07375.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  27 in total

1.  pUV I: a new vaccinia virus insertion and expression vector.

Authors:  F G Falkner; S Chakrabarti; B Moss
Journal:  Nucleic Acids Res       Date:  1987-09-11       Impact factor: 16.971

2.  The beta-amyloid protein precursor of Alzheimer disease has soluble derivatives found in human brain and cerebrospinal fluid.

Authors:  M R Palmert; M B Podlisny; D S Witker; T Oltersdorf; L H Younkin; D J Selkoe; S G Younkin
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

3.  Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease.

Authors:  B A Yankner; L R Dawes; S Fisher; L Villa-Komaroff; M L Oster-Granite; R L Neve
Journal:  Science       Date:  1989-07-28       Impact factor: 47.728

4.  Evidence of amyloid beta-protein immunoreactive early plaque lesions in Down's syndrome brains.

Authors:  S Ikeda; N Yanagisawa; D Allsop; G G Glenner
Journal:  Lab Invest       Date:  1989-07       Impact factor: 5.662

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 6.  Alzheimer's disease.

Authors:  R Katzman
Journal:  N Engl J Med       Date:  1986-04-10       Impact factor: 91.245

7.  A4 amyloid protein deposition and the diagnosis of Alzheimer's disease: prevalence in aged brains determined by immunocytochemistry compared with conventional neuropathologic techniques.

Authors:  L Davies; B Wolska; C Hilbich; G Multhaup; R Martins; G Simms; K Beyreuther; C L Masters
Journal:  Neurology       Date:  1988-11       Impact factor: 9.910

8.  A variety of cerebral amyloid deposits in the brains of the Alzheimer-type dementia demonstrated by beta protein immunostaining.

Authors:  H Yamaguchi; S Hirai; M Morimatsu; M Shoji; Y Ihara
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

9.  Beta-amyloid precursor protein of Alzheimer disease occurs as 110- to 135-kilodalton membrane-associated proteins in neural and nonneural tissues.

Authors:  D J Selkoe; M B Podlisny; C L Joachim; E A Vickers; G Lee; L C Fritz; T Oltersdorf
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

10.  A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors.

Authors:  P Ponte; P Gonzalez-DeWhitt; J Schilling; J Miller; D Hsu; B Greenberg; K Davis; W Wallace; I Lieberburg; F Fuller
Journal:  Nature       Date:  1988-02-11       Impact factor: 49.962

View more
  6 in total

1.  Expression of active secreted forms of human amyloid beta-protein precursor by recombinant baculovirus-infected insect cells.

Authors:  R Bhasin; W E Van Nostrand; T Saitoh; M A Donets; E A Barnes; W W Quitschke; D Goldgaber
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

2.  High-level expression and in vitro mutagenesis of a fibrillogenic 109-amino-acid C-terminal fragment of Alzheimer's-disease amyloid precursor protein.

Authors:  J E Gardella; G A Gorgone; L Candela; J Ghiso; E M Castaño; B Frangione; P D Gorevic
Journal:  Biochem J       Date:  1993-09-15       Impact factor: 3.857

3.  Brain transplants of cells expressing the carboxyl-terminal fragment of the Alzheimer amyloid protein precursor cause specific neuropathology in vivo.

Authors:  R L Neve; A Kammesheidt; C F Hohmann
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

4.  Deposition of beta/A4 immunoreactivity and neuronal pathology in transgenic mice expressing the carboxyl-terminal fragment of the Alzheimer amyloid precursor in the brain.

Authors:  A Kammesheidt; F M Boyce; A F Spanoyannis; B J Cummings; M Ortegón; C Cotman; J L Vaught; R L Neve
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

5.  Intracellular accumulation of amyloidogenic fragments of amyloid-beta precursor protein in neurons with Niemann-Pick type C defects is associated with endosomal abnormalities.

Authors:  Lee-Way Jin; Feng-Shium Shie; Izumi Maezawa; Inez Vincent; Thomas Bird
Journal:  Am J Pathol       Date:  2004-03       Impact factor: 4.307

6.  Intraneuronal aggregation of the β-CTF fragment of APP (C99) induces Aβ-independent lysosomal-autophagic pathology.

Authors:  Inger Lauritzen; Raphaëlle Pardossi-Piquard; Alexandre Bourgeois; Sophie Pagnotta; Maria-Grazia Biferi; Martine Barkats; Pascale Lacor; William Klein; Charlotte Bauer; Frederic Checler
Journal:  Acta Neuropathol       Date:  2016-04-30       Impact factor: 17.088

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.